Biliary Tract Cancer Not Yet Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Biliary tract cancer / Cancers, Biliary Tract / Malignant neoplasm of biliary tract, unspecified / Malignant tumor of biliary tract / Malignant neoplasm of biliary tract, part unspecified

IndicationStatusPhase
DBCOND0030617 (Biliary Tract Cancer)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03110328Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular SubtypesTreatment
NCT03260712Pembrolizumab in Biliary Tract CancerTreatment